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Hydrogels micro, sub-micro and nanoparticles are of great interest for drug encapsulation and delivery or as embolotherapic agents. 
In this work it is described the preparation of nano and sub-microparticles of pre-formed, high molecular weight and monomer free 
poly(N-vinyl-2-pyrrolidone) encapsulated inside the core of lecithin vesicles. The hydrogel particles are formed with a very narrow 
diameter distribution, of about 800 nm, and a moderate swelling ratio, of approximately 10.
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INTRODUCTION
Hydrogel nanoparticles (nanogels) are of interest due to their 
ability to combine the advantages of biocompatibility, inherent to 
most hydrogels,1 and small size.2 Potential applications of nanogels 
include controlled drug delivery systems3 (oral4 and/or parenteral5 
delivery) and alternative therapies, like embolotherapy.6
Nanogels can be obtained from monomer polymerization in presence 
of difunctional monomers, either in w/o emulsions7,8 or using the core 
of reverse micelles as formatting system.9 Alternatively, nanogels can 
be prepared by inclusion in reverse micelles of pre-formed polymers, 
followed by crosslinking.10 Vesicles also can be used to obtain hydrogels 
nanoparticles, by monomer encapsulation followed by polymerization11 
or gelation of encapsulated polymers, generally induced by sol-gel tem-
perature transitions12 or ionic crosslinking,13 typically without removal 
of the lipid bilayer.14 These gel-like vesicles work as cell models, since 
they have elastic modulus comparable to that of cell cytoplasm14 and 
are considered artificial cytoskeletons.14,15 Vesicles containing poly(N-
isopropylacrylamide) are good examples. This polymer responds to 
temperature changes forming physical gels on a reversible process, even 
within vesicles.16 This temperature induced sol-gel transition within the 
vesicle mimics cell stiffening.12 Hydrogel-liposome assemblies (lipobea-
ds) can also be used as drug delivery systems.17 The lipid bilayer is often 
left intact and the encapsulated polymer is not crosslinking. 
Vesicles have advantages compared to other systems for produ-
cing nanogels, since these assemblies permit more diameter control 
alternatives.18 The particle diameter can be controlled varying the 
vesicles diameter from a few nanometers to millimeters and can be 
obtained with a narrow size distribution. Vesicles can be prepared 
using low amounts of non-toxic solvents and this compares favorably 
with other methods such as emulsion polymerization. The major 
component of a vesicle preparation is water and a non-toxic surfac-
tant can be chosen, thereby resulting in a biocompatible preparation.
Poly(N-vinyl-2-pyrrolidone) hydrogels can be prepared by several 
straightforward methodologies.19-22 One of these methods involves the 
use of photo-Fenton reaction21, using ferric ions, hydrogen peroxide 
and UVA radiation.22 
Here we describe the use of lecithin vesicles as formatting sys-
tem to obtain poly(N-vinyl-2-pyrrolidone) hydrogel particles, using 
photo-Fenton or Fenton reactions for crosslinking.
EXPERIMENTAL
Materials
Egg phosphatidylcholine was purified from egg yolks as 
described by Maximiano et al..23 Soy lecithin was obtained from 
crude soy lecithin capsules by purification with the same method 
used for egg phosphatidilcholine.23 Dioctadecyldimethylammo-
nium chloride (DODAC) was obtained from the bromide salt 
(DODAB; Aldrich) after ion exchange with a Dowex-21K resin 
(Fluka) in the chloride form in methanol. 1,2-Dipalmitoyl-3-
trimethylammonium-propane chloride (DPTMA) was synthesized 
as described previously24 as bromide salt, which was exchanged 
for chloride as indicated for DODAC. Poly(N-vinyl-2-pyrrolidone) 
(PVP) (Plasdone K90, —M
w
 = 1,300,000) was kindly donated by 
BASF. FeCl2, FeCl3 and H2O2 30% (Aldrich), NaCl (Merck) and 
CH2Cl2 (Synth Brazil) were analytical grade and used as received. 
Water was deionized.
Methods
PVP encapsulation in liposome
PVP containing vesicles were obtained as follows (Figure 
1): 0.5 mL of a CH2Cl2 solution containing 50 mg of egg or soy 
phosphatidylcholine (100 mg mL-1) were injected into 5 mL of 
PVP aqueous solution (80 g L-1), containing 17 mmol L-1 FeCl2 
maintained at 50 ºC. CH2Cl2 solution was injected with a syringe 
adapted in a KD Scientific Inc. Model KDS120 Push-Pull Pump, 
equipped with a fine-gauge needle (No 3D). During injection, a 
N2 stream was bubbled into PVP solution, which continued after 
liposome formation until removal of residual solvent. Liposome 
suspension was centrifuged at 22,800 × g for 30 min (Hitachi 
Himac CR20B2 centrifuge; Hitachi Ltd.) at 25 ºC to remove 
non-entrapped polymer from the external phase. The liposome-
containing pellet was washed twice by centrifugation under same 
conditions in saline solution (51 mmol L-1). The washed pellet was 
suspended on 20 mL of NaCl(aq). 
PVP concentration inside vesicles was estimated using Lugol 
method.25 Resulting PVP complex with Lugol Reagent (PVP-I3-) 
absorbs at 400 nm, and the PVP concentration was obtained using 
appropriate calibration curve. The encapsulation yield (EY) was 
calculated using Equation 1.
Bueno et al.2084 Quim. Nova
  (1)
where  is the mass of encapsulated PVP in the vesicles pellet 
and 0.4 is the mass of PVP in the initial solution (in g).
PVP entrapped polymerization
To crosslink PVP inside the vesicles, 4 mL of H2O2 diluted on 
NaCl(aq) (51 mmol L-1) was added to the PVP-containing vesicles 
([H2O2]final = 200 mmol L-1).22 As Fe2+ can be oxidized to Fe3+ inside 
vesicles before H2O2 addition, to promote crosslinking by photo-
Fenton reaction21 H2O2 containing vesicles suspension was submitted 
to 12 h of UV radiation (360 nm). The hydrogel particles were purified 
by lysing vesicles washing 3× with ethanol 50%. The resulting pellet 
was resuspended in water and freeze-dried.
Dynamic light scattering measurements
The determination of particles size distribution was carried out by 
dynamic light scattering (DLS), using a spectrometer from Brookha-
ven Instruments. The average hydrodynamic diameters were obtained 
from the unimodal distribution of particles analyzed by Zeta PALS 
Particle Sizing Software Version 2.29.
Scanning electron microscopy (SEM)
Particles were analyzed by SEM (FEG-SEM, model FEG 7401F, 
from Jeol). Samples were prepared by fixing the particles (freeze-
dried powder) on a double-face copper tape and the specimens were 
analyzed without coating.
Swelling ratio determination (Q)
Swelling ratio (Q) determination was done by weighing the 
swollen particles pellet in an analytical balance (m
swo
), followed by 
freeze drying and weighing the dry pellet (mdry). Q was calculated 
directly by Equation 2.
  (2)
RESULTS AND DISCUSSION
Polymer encapsulation
The efficiency of vesicle encapsulation depends on polymer size 
and decreases with the increase of polymer molecular weight.26,27 
Szoka and Papahadjopoulos28 found that encapsulation efficiency 
decreases with the increase of molecular weight of the encapsulated 
protein. Dominak et al.26 observed the same inverse relationship 
between encapsulation efficiency and molecular weight studying 
polyethylene glycol and dextran encapsulation in giant vesicles. To 
encapsulate PVP, various surfactants were tested, including lecithin 
from egg yolk and soybeans and cationic surfactants. Table 1 shows 
the surfactants and their respective PVP encapsulation yield. As 
each vesicle in solution can have different encapsulation values,26 
it is important to emphasize that PVP inclusion was measured by 
estimating the total amount that was incorporated and therefore the 
incorporation represents an average over all vesicles.
The best encapsulation efficiency was obtained with soy lecithin 
vesicles. Lecithins of different sources exhibit distinct properties.23,29 
In particular the length of the apolar portion of the molecule and the 
insaturation of the alkyl chain will result in vesicles with different 
properties.30 The method used to obtain vesicle encapsulated PVP 
also contributes to high encapsulation efficiency.18
Since the method used to crosslink the encapsulated polymer 
requires long irradiation times (photo-Fenton reaction), the addition 
Table 1. PVP encapsulation in obtained vesicles
Surfactant EY (%)
Egg lecithin 0.8 ± 0.1 
Soy lecithin 2.0 ± 0.3
DPPC 0.6 ± 0.1
DODAC 1% + soy lecithin 0.4 ± 0.1
DPTMA 1% + soy lecithin 2.0 ± 0.4
Figure 1. Production of PVP hydrogel particles
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of cationic surfactants decreases vesicle aggregation during irradiation 
by increasing vesicle repulsion. Two saturated surfactants where tes-
ted: DODAC and DPTMA. Encapsulation efficiency was higher with 
DPTMA than with DOCAC. DODAC contains two octadecyl chains 
linked to the tetraalkylammonium group; in DPTMA the acyl chains 
are attached to a propanediol moiety linked to tetraalkylammonium 
group (Figure 2). Bilayer packing defects are expected31,32 upon 
incorporation of DODAC to lecithin causing a decrease in polymer 
entrapment. Measurements of polymer leak showed that entrapped 
PVP was retained after several washes (supernatant PVP concentra-
tion was measured as <10-4 g L-1 for DPPC vesicles and as 0.02 g L-1 
for DODAC/lecithin vesicles, after 5 wash cycles). 
Crosslinking reaction
Two methods were used to crosslink the polymer. The Fenton 
reaction, an efficient method to obtain PVP hydrogels with good 
mechanical properties,22 has been used to obtain PVP nanogels with 
superabsorbent properties.10 Photo-Fenton reaction, a photochemical 
analog of Fenton reaction, also produces PVP hydrogels21 (Scheme 1).
The Fenton reaction is interesting because it allows a fast route to 
obtain PVP hydrogels with any desired format.33 However, this reac-
tion requires Fe2+ which autoxidizes. On the other hand, photo-Fenton 
reaction uses Fe3+ ions, H2O2 and UV radiation (λ = 365 nm). Since 
the vesicles can scatter and react with H2O2 (lipoperoxidation), the 
UV dose and H2O2 concentrations were higher than those described.21
Fenton and photo-Fenton reactions did not change significantly 
the vesicles diameter distribution (Figures 3 and 4). This finding 
does not imply that the lipid bilayer remains unchanged during 
crosslinking reaction, since hydroxyl radical is known to react with 
unsaturated acyl chains.34
Particle characterization
When conventional Fenton reaction was used no pellet was 
obtained after vesicle´s lysis, evidencing absence of crosslinking, 
probably due Fe2+ depletion via its autoxidation. A phosphorus-free 
yellow pellet was obtained after crosslinking by photo-Fenton reac-
tion and vesicles lyses.39 This pellet was resuspended in water and 
analyzed by SEM and DLS. Results demonstrated the presence of a 
formless particulate material with dimensions comparable to vesicles 
(Figures 5 and 6).
The diameter of nano and sub-microgel and nanogel particles can be 
controlled by choosing the vesicle preparation method. Polyacrylamide 
nanogels (from monomers) covered by phospholipids bilayers obtained 
by detergent depletion35 or freeze-thaw cycles followed by extrusion36/
sonication11,17 presented diameters of 100 and 200 nm, respectively. 
Larger nanogels (about 450 nm) are obtained from encapsulation of 
20% dextran hydroyethylmethacrylate solution ( –Mn= 19000) inside 
vesicles obtained by phospholipids film hydration, followed by extru-
Figure 2. Structures of (A) DPTMA and (B) DODAC
Scheme 1. Hydroxyl radical generation from Fenton and photo-Fenton 
reactions
Figure 3. Diameter distribution of egg lecithin vesicles containing PVP. (A) 
vesicles submitted to Fenton reaction; (B) vesicles submitted to photo-Fenton 
reaction and (C) vesicles prior to crosslinking reaction
Figure 4. Diameter distribution of soy lecithin vesicles containing PVP. 
(A) vesicles submitted to photo-Fenton reaction and (B) vesicles prior to 
crosslinking reaction
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sion.37 Poly(ethylenedioxythiophene)/poly(styrenesulfonate)13 and 
poly(N-isopropylacrylamide)12,16 microgels, in conjunction with lipid 
bilayers, are obtained by injecting a polymer solution inside GUVs, 
followed by freeze-thaw cycles and electroporation. The vesicle diam-
eters, in these latter cases, vary from 5 to 100 µm. 
The hydrogel particles obtained here showed no defined morphol-
ogy, in spite of being obtained from spherical vesicles. Vesicles may 
be destabilized during crosslinking by H2O2 oxidation and ensuing 
lipoperoxidated38 (Figure 7). Fluctuation of crosslinking density, known 
to influence hydrogel particle morphology, may also account for the 
lack of defined shape.13 Non spherical particles have also been reported 
with other nanogels prepared using vesicles.17,37
Particle swelling was estimated directly and the swelling ratio (Q) 
was 10, i.e., particles absorb only 10 times their mass in water. This 
is a strong indication that the crosslinking density is high since Q is 
inversely proportional to the ability of absorbing water.
Swelling of nanogels formatted from vesicles has seldom 
been discussed in literature. In the case of poly(N-isopropyl 
acrylamide) hydrogels and copolymers, coagulation of particles 
was observed instead of the variation in swelling. Kasakov et al. 
have extensively studied this systems11,17,36 mainly in regard to the 
interaction between particle and liposome. Since the hydrogel used 
Figure 5. SEM image of freeze-dried particles obtained from egg lecithin 
vesicles (A) and DLS particles diameter distribution (B)
Figure 6. SEM image of freeze-dried particles obtained from soy lecithin 
vesicles (A) and DLS particles diameter distribution (B)
is thermo- and pH-responsive, coagulation was observed upon 
heating, including coagulation of the lipid bilayer, which, after 
Figure 7. SEM image of particles obtained from soy lecithin vesicles with 
10% DPTMA
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cooling, surround the entire set of nanoparticles in a reversible 
process.36 The authors also observed an increase in diameter with 
pH change: 100 nm at pH 6.5 to 300 nm at pH 3.0, with dimeriza-
tion of particles.17
CONCLUSION
Injected lecithin vesicles can encapsulate high molecular weight 
PVP. The encapsulated polymer can be crosslinked by photo-Fenton 
reaction and hydrogel nano and sub-microparticles can be isolated. 
Spherical morphology was not achieved, but the produced hydrogel 
particles have a narrow diameter distribution compatible with the 
vesicles diameter distribution.
REFERENCES
 
 1.  Rosiak, J. M.; Yoshii, F.; Nucl. Instrum. Methods Phys. Res., Sect. B 
1999, 151, 56.
 2.  Tao, S. L.; Desai, T. A.; Adv. Drug Delivery Rev. 2003, 55, 315.
 3.  Mathews, A.; Ha, C.-S.; Cho, W.-J.; Kim, I.; Drug Delivery 2006, 13, 
245.
 4.  Mundargi, R. C.; Patil, S. A.; Kulkarni, P. V.; Mallikarjuna, N. N.; 
Aminabhavi, T. M.; J. Microencapsulation 2008, 25, 228. 
 5.  Nguyen, K. T.; Shukla, K. P.; Moctezuma, M.; Braden, A. R. C.; Zhou, 
J.; Hu, Z.; Tang, L.; J. Biomed. Mater. Res., Part A 2009, 88, 1022.
 6.  Rao, V. R.; Ravimandalam, K.; Jayakrishnan, A.; Thanoo, B. C.; 
Radhakrishnan, V. V.; Gupta, A. K.; Kumar, S.; Joseph, S.; Unni, M.; 
Rao, A. S.; J. Neuroradiology 1991, 18, 61.
 7.  Sahiner, N.; Godbey, W. T.; Mcpherson, G. L.; John, V. T.; Colloid 
Polym. Sci. 2006, 284, 1121.
 8.  Imaz, A.; Forcada, J.; Macromol. Symp. 2009, 281, 85. 
 9.  Bharali, D. J.; Sahoo, S. K.; Mozumdar, S.; Maitra, A. J.; J. Colloid 
Interface Sci. 2003, 258, 415.
 10.  Bueno, V. B.; Cuccovia, I. M.; Chaimovich, H.; Catalani, L. H.; Colloid 
Polym. Sci. 2009, 287, 705.
 11.  Kazakov, S.; Kaholek, M.; Kudasheva, D.; Teraoka, I.; Cowman, M. K.; 
Levon, K.; Langmuir 2003, 19, 8086.
 12.  Jesorka, A.; Markstroem, M.; Orwar, O.; Langmuir 2005, 21, 1230.
 13.  Jesorka, A.; Markstroem, M.; Karlsson, M.; Orwar, O.; J. Phys. Chem. 
B 2005, 109, 14759.
 14.  Kremer, S.; Campillo, C.; Pepin-Donat, B.; Viallat, A.; Brochard-Wyart, 
F.; EPL 2008, 82, 48002/1.
 15.  Campillo, C.; Pepin-Donat, B.; Viallat, A.; Soft Matter 2007, 3, 1421.
 16.  Markstroem, M.; Gunnarsson, A.; Orwar, O.; Jesorka, A.; Soft Matter 
2007, 3, 587.
 17.  Kazakov, S.; Levon, K.; Curr. Pharm. Des. 2006, 12, 4713.
 18.  Lasic, D. D.; Biochem. J. 1988, 256, 1.
 19.  Rosiak, J. M.; J. Controlled Release 1994, 31, 9.
 20.  Kadlubowski, S.; Henke, A.; Ulanski, P.; Rosiak, J. M.; Bromberg, L.; 
Hatton, T. A.; Polymer 2007, 48, 4974. 
 21.  Fechine, G. J. M.; Barros, J. A. G.; Catalani, L. H.; Polymer 2004, 45, 
4705.
 22.  Barros, J. A. G.; Fechine, G. J. M.; Alcantara, M. R.; Catalani, L. H.; 
Polymer 2006, 47, 8414.
 23.  Maximiano, F. A.; da Silva, M. A.; Daghastanli, K. R. P.; de Araujo, P. 
S.; Chaimovich, H.; Cuccovia, I. M.; Quim. Nova 2008, 31, 910.
 24.  Moss, R. A.; Gangulu, S.; Okumura, Y.; Fujita, T.; J. Am. Chem. Soc. 
1990, 112, 6391.
 25.  Leger, C.; Nguyen, Q. T.; Neel, J.; Streicher, C.; Macromolecules 1995, 
28, 143.
 26.  Dominak, L. M.; Keating, C. D.; Langmuir 2007, 23, 7148.
 27.  Dominak, L. M.; Keating, C. D.; Langmuir 2008, 24, 13565.
 28.  Szoka, F., Jr.; Papahadjopoulos, D.; Annu. Rev. Biophys. Bioeng. 1980, 
9, 467.
 29.  Palacios, L. E.; Wang, T.; J. Am. Oil Chem. Soc. 2005, 82, 571. 
 30.  Nagarajan, R.; Ruckenstein, E.; J. Colloid Interface Sci. 1979, 71, 580.
 31.  Kumar, V. V.; Indian J. Biochem. Biophys. 1993, 30, 135.
 32.  Batenjany, M. M.; Wang, Z.-Q.; Huang, C.-H.; Levin, I. W.; Biochim. 
Biophys. Acta, Biomembr. 1994, 1192, 205.
 33.  Catalani, L. H.; Fechine, G. J. M.; Barros, J. A. G.; BR PI 0402081-2 
2006. (CA 147:508389)
 34.  Megli, F. M.; Sabatini, K.; Chem. Phys. Lipids 2003, 125, 161. 
 35.  Schillemans, J. P.; Flesch, F. M.; Hennink, W. E.; van Nostrum, C. F.; 
Macromolecules 2006, 39, 5885.
 36.  Kazakov, S.; Kaholek, M.; Teraoka, I.; Levon, K.; Macromolecules 
2002, 35, 1911.
 37.  van Thienen, T. G.; Lucas, B.; Flesch, F. M.; Nostrum, C. F.; Demeester, 
J.; De Smedt, S. C.; Macromolecules 2005, 38, 8503.
 38.  Dobretsov, G. E.; Borschevskaya, T. A.; Petrov, V. A.; Vladimirov, Yu. 
A.; FEBS Lett. 1977, 84, 125.
 39.  Rouser, G.; Fleischer, S.; Yamamoto, A.; Lipids 1970, 5, 494.
